These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 32391806)

  • 41. T Cells and Cerebral Ischemic Stroke.
    Gu L; Jian Z; Stary C; Xiong X
    Neurochem Res; 2015 Sep; 40(9):1786-91. PubMed ID: 26220139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adoptive regulatory T-cell therapy protects against cerebral ischemia.
    Li P; Gan Y; Sun BL; Zhang F; Lu B; Gao Y; Liang W; Thomson AW; Chen J; Hu X
    Ann Neurol; 2013 Sep; 74(3):458-71. PubMed ID: 23674483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain-immune interactions and ischemic stroke: clinical implications.
    Kamel H; Iadecola C
    Arch Neurol; 2012 May; 69(5):576-81. PubMed ID: 22782509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toll-like receptors in cerebral ischemic inflammatory injury.
    Wang YC; Lin S; Yang QW
    J Neuroinflammation; 2011 Oct; 8():134. PubMed ID: 21982558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke.
    Singh V; Roth S; Veltkamp R; Liesz A
    Antioxid Redox Signal; 2016 Apr; 24(12):635-51. PubMed ID: 26493086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immune responses and neuroimmune modulation in the pathogenesis of acute ischemic stroke and poststroke infections].
    Papp V; Molnár T; Bánáti M; Illés Z
    Ideggyogy Sz; 2010 Jul; 63(7-8):232-46. PubMed ID: 20812451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans.
    Haeusler KG; Schmidt WU; Föhring F; Meisel C; Helms T; Jungehulsing GJ; Nolte CH; Schmolke K; Wegner B; Meisel A; Dirnagl U; Villringer A; Volk HD
    Cerebrovasc Dis; 2008; 25(1-2):50-8. PubMed ID: 18033958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of microglia with infiltrating immune cells in the different phases of stroke.
    Berchtold D; Priller J; Meisel C; Meisel A
    Brain Pathol; 2020 Nov; 30(6):1208-1218. PubMed ID: 33058417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory T cells in ischemic stroke.
    Wang HY; Ye JR; Cui LY; Chu SF; Chen NH
    Acta Pharmacol Sin; 2022 Jan; 43(1):1-9. PubMed ID: 33772140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ischemic transient neurological events identified by immune response to cerebral ischemia.
    Jickling GC; Zhan X; Stamova B; Ander BP; Tian Y; Liu D; Sison SM; Verro P; Johnston SC; Sharp FR
    Stroke; 2012 Apr; 43(4):1006-12. PubMed ID: 22308247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting neutrophils in ischemic stroke: translational insights from experimental studies.
    Jickling GC; Liu D; Ander BP; Stamova B; Zhan X; Sharp FR
    J Cereb Blood Flow Metab; 2015 Jun; 35(6):888-901. PubMed ID: 25806703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain Cleanup as a Potential Target for Poststroke Recovery: The Role of RXR (Retinoic X Receptor) in Phagocytes.
    Ting SM; Zhao X; Sun G; Obertas L; Ricote M; Aronowski J
    Stroke; 2020 Mar; 51(3):958-966. PubMed ID: 31914884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory Disequilibrium in Stroke.
    Petrovic-Djergovic D; Goonewardena SN; Pinsky DJ
    Circ Res; 2016 Jun; 119(1):142-58. PubMed ID: 27340273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoreactive Cells After Cerebral Ischemia.
    Wang Y; Zhang JH; Sheng J; Shao A
    Front Immunol; 2019; 10():2781. PubMed ID: 31849964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke.
    Lee Y; Lee SR; Choi SS; Yeo HG; Chang KT; Lee HJ
    Biomed Res Int; 2014; 2014():297241. PubMed ID: 25089266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation as therapeutic objective in stroke.
    Jordán J; Segura T; Brea D; Galindo MF; Castillo J
    Curr Pharm Des; 2008; 14(33):3549-64. PubMed ID: 19075732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune and inflammatory responses to stroke: good or bad?
    McCombe PA; Read SJ
    Int J Stroke; 2008 Nov; 3(4):254-65. PubMed ID: 18811742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral stroke injury: the role of cytokines and brain inflammation.
    Siniscalchi A; Gallelli L; Malferrari G; Pirritano D; Serra R; Santangelo E; De Sarro G
    J Basic Clin Physiol Pharmacol; 2014 May; 25(2):131-7. PubMed ID: 24515999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.